
Consulting Firm to Pharma and Biotech Cos.
Consulting Firm to Pharma and Biotech Cos.
Amazing Opportunity for Strategic or Private Equity Buyer!
The business provides commissioning, qualification and validation (CQV) consulting services to pharmaceutical, biopharmaceutical, medical device and diagnostics manufacturers via a team of expert consultants. The service it provides includes new facility start-ups, modifications to existing facilities / equipment, regulatory inspections, and remediations. Over the last few years, the business had enjoyed hockey stick-like growth in terms of reputation, revenues and profit. An estimated 75% of the company’s sales are generated from recurring business through existing clients.
To partner with the new owner to drive growth.
The owner is not looking to sell, provide transitionary support, and eventually move on. Their objective is to remove some of the risk and burden of running a business with explosive growth, and partner with the new owner to take the business to the next level.
The owner operates the business from their home-based office as well as on-site at client facilities.
The evolution of many US companies to a leaner business model has created a greater demand for consultants and many companies in various industries outsource to obtain expertise in structuring and directing their complicated business operations. Many US businesses retain consultants as a matter of course, not only when issues arise, and this has contributed to the substantial growth of the consulting industry. In addition, the rapid and continuous growth of the health care and biotechnology / pharmaceutical sector, provides ideal market conditions.
The aging population in the US is a driving force to the robust market conditions. The current demand far exceeds the company's ability to meet it. That is one of the primary reasons for the owner is looking to sell the business and partner with the next owner.
The owner is open to a range of options with a qualified buyer.